Introduction
============

Glycerol-3-phosphate (G3P) feeds into glycolysis and gluconeogenesis, and serves as a precursor for the synthesis of membrane lipids and storage lipids. In addition, G3P participates in a mitochondrial shuttle to channel reducing equivalents from the cytosol into the mitochondria for respiration (Shen et al., [@B29]). Plants have multiple mechanisms for the synthesis of G3P. For example, glycerol kinase catalyzes the phosphorylation of glycerol to yield G3P. In *Arabidopsis thaliana*, the *NHO1* (also known as *GLI1*)-encoded glycerol kinase synthesizes G3P in the cytosol (Kang et al., [@B18]). Another G3P biosynthesis mechanism involves the NADH-dependent reduction of dihydroxyacetone phosphate (DHAP) by DHAP reductases (Gee et al., [@B11]; Kirsch et al., [@B19]). DHAP reductases are generally grouped with and referred to as G3P dehydrogenase (GPDH). In animals, GPDH catalyze the oxidation of G3P to DHAP. However, in plants, at the physiological pH, most of these enzymes are essentially inactive as GPDHs, functioning only as DHAP reductases (Gee et al., [@B11]; Kirsch et al., [@B19]; Wei et al., [@B34]; Shen et al., [@B29]).

Four DHAP reductases/GPDHs have been studied in *Arabidopsis*. The At2g41540-encoded GPDHc1, which is located in the cytosol, functions along with the At3g10370-encoded mitochondrial FAD-dependent GPDH (FAD--GPDH) to shuttle reducing equivalents into the mitochondria for respiration (Shen et al., [@B30], [@B29]). In contrast, the At5g40610-encoded DHAP reductase contains a plastid transit peptide at its N-terminus and is suggested to function in the plastids (Wei et al., [@B34]). The *SFD1* (also known as *GLY1*) gene (At2g40690) encodes another DHAP reductase, which was shown to be required for glycerolipid synthesis in the chloroplasts (Miquel et al., [@B23]; Kachroo et al., [@B17]; Nandi et al., [@B25]). Loss-of-function mutations in this gene impact the acyl composition of monogalactosyldiacylglycerol (MGDG; Miquel et al., [@B23]; Nandi et al., [@B25]), resulting in a substantial reduction in levels of the chloroplast synthesized 18:3--16:3 acyl chain containing 34:6-MGDG species and a parallel increase in the levels of 18:3--18:3 acyl chain containing 36:6-MGDG, which is presumably derived from diacylglycerol that has been shunted from the cytosol into the chloroplast as a compensatory mechanism.

In *Arabidopsis*, enzymes involved in the synthesis of G3P also function in stress response. For example, *GPDHc1* expression was induced in response to stress imposed by high salt and dehydration (Shen et al., [@B29]). *GPDHc1* expression was also induced in response to treatment with abscisic acid, an important stress hormone. Plants lacking *GPDHc1* function were impaired in maintaining cellular redox homeostasis, which resulted in a higher steady state level of reactive oxygen species in the *gpdhc1* mutant plant and a corresponding increase in ROS scavenging enzymes (Shen et al., [@B29]). In line with a role for *GPDHc1* in plant stress response, the mutant plant exhibited heightened sensitivity to salt stress and abscisic acid (Shen et al., [@B29]). The *NHO1* gene is also involved in plant stress response. *NHO1* is required for resistance against non-host and avirulent strains of *Pseudomonas* spp. (Kang et al., [@B18]). *NHO1* expression is induced in plants inoculated with these pathogens. Furthermore, loss of *NHO1* function resulted in increased growth of these pathogens in the *nho1* mutant. In contrast, *NHO1*-mediated resistance is overcome by virulent strains of *Pseudomonas syringae*, which suppress *NHO1* expression. *NHO1* is also required for resistance against the fungal pathogen *Colletotrichum higginsianum* (Chanda et al., [@B2]).

Like *NHO1*, *SFD1* is also involved in plant defense against pathogens. Although not required for basal resistance to *P. syringae* (Nandi et al., [@B25]; Chaturvedi et al., [@B4]), *SFD1* is required for *Arabidopsis* resistance against *C. higginsianum* (Chanda et al., [@B2]). *SFD1* is also required for systemic acquired resistance (SAR; Nandi et al., [@B25]; Chaturvedi et al., [@B4]; Chanda et al., [@B3]), which is an inducible defense mechanism that is activated systemically throughout the foliage in response to a prior exposure to pathogen elsewhere on the foliage (Métraux et al., [@B21]; Durrant and Dong, [@B10]; Vlot et al., [@B33]; Shah, [@B28]). The activation of SAR requires the translocation of a signal from the pathogen-inoculated organ to rest of the foliage, where it stimulates salicylic acid accumulation and enhances resistance against subsequent infections. The vasculature is the conduit for the long-distance translocation of this signal (Heil and Ton, [@B12]; Shah, [@B28]). *sfd1* Mutant plants are defective in this long-distance signaling (Chaturvedi et al., [@B4]). Unlike vascular sap-enriched petiole exudates collected from wild type (WT) leaves treated with a SAR-inducing pathogen, comparable exudates collected from the *sfd1* mutant leaves were unable to activate SAR when applied to leaves of the WT plant (Chaturvedi et al., [@B4]). By contrast, the *sfd1* mutant leaves were sensitive to the SAR-inducing activity contained in WT petiole exudates. Considering that mutations in *sfd1* impact lipid metabolism (Miquel et al., [@B23]; Kachroo et al., [@B17]; Nandi et al., [@B25]), it was suggested that a lipid or a lipid-derived factor was required for the accumulation in the vasculature and/or long-distance translocation of a SAR-inducing activity (Chaturvedi et al., [@B4]). Alternatively, G3P, which has been shown to impact plant defenses (Kachroo and Kachroo, [@B16]; Chanda et al., [@B3]), could have a more direct role in SAR. However, the molecular mechanism of SFD1's involvement in SAR signaling remains unclear.

*SFD1* encodes a 420 amino acid protein (Figure [1](#F1){ref-type="fig"}A). The *sfd1-1* and *gly1-2* alleles contain G → A transition mutations within the first 500 nucleotides of the *SFD1* coding region that likely impact splicing of the *SFD1* RNA (Kachroo et al., [@B17]; Nandi et al., [@B25]). In contrast, the *gly1-3* allele contains a nonsense mutation that is predicted to result in a truncated protein lacking the C-terminal 109 amino acids (Kachroo et al., [@B17]), which includes part of the predicted DHAP-binding domain (Figure [1](#F1){ref-type="fig"}A), and the *sfd1-2* allele contains a mis-sense mutation that results in the replacement of Ala at amino acid position 381 with Thr (Nandi et al., [@B25]). Although this alteration in *sfd1-2* is within the DHAP-binding domain, it is not within the predicted active site region of the protein. Thus, the existing data does not exclude the possibility that the involvement of SFD1 in SAR is independent of its DHAP reductase activity. Indeed, moonlighting, that is having more than one biochemical function, is not uncommon for proteins (Jeffery, [@B13]; Moore, [@B24]). For example, in humans, the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase also possesses a protein kinase activity and a uracil glycosylase activity that is involved in DNA repair (Meyer-Siegler et al., [@B22]). Likewise, a plant ferredoxin-dependent glutamate synthase was shown to form a complex with UDP-sulfoquinovose synthase and thus participate in sulfolipid biosynthesis, in addition to its role in amino acid metabolism (Shimojima et al., [@B31]). Thus, it is important to determine if SFD1's DHAP reductase activity is required for the activation of SAR.

![**Amino acid sequence and functional domains of SFD1 protein and their alignment with the *Leishmania mexicana* GPDH**. **(A)** InterProScan predicted NAD-dependent glycerol-3-phosphate dehydrogenase domain (residues 88--250) indicated in red, and a NAD-dependent glycerol-3-phosphate dehydrogenase C-terminal domain (residues 267--411) indicated in blue. The putative N-terminal chloroplast transit peptide as predicted by iPSORT is overlined. The Gly residues in the GxGxxG NAD-binding motif that is conserved amongst most GPDHs, and the active site residues Lys194, Lys279, and Asp332, which were chosen for site-directed mutagenesis, are in bold black and underlined. **(B)** Alignment of SFD1 protein to *Leishmania mexicana* GPDH. ClustalW software was used to obtain multiple sequence alignment between SFD1 and the 1EVYA (GenBank accession: MT5G51560) GPDH from *Leishmania mexicana*. Active site residues in LmGPDH (Lys125, Ser155, Ala157, Lys210, Asn211, Asp263, Thr267, Ser273, Arg274, and Asn275) are indicated in bold red and underlined, and the corresponding residues of SFD1 indicated in bold red. Other residues that are identical between LmGPDH and SFD1 are in bold blue. The NAD-dependent glycerol-3-phosphate dehydrogenase N-terminal domain is overlined with a dashed line, while a solid overline denotes the C-terminal NAD-dependent glycerol-3-phosphate dehydrogenase domain.](fpls-03-00026-g001){#F1}

Since the major lipid defect in the *sfd1* mutant is the reduction in levels of the plastid synthesized 34:6-MGDG, we had suggested that SFD1 likely functions in the plastids (Nandi et al., [@B25]). However, there is a lack of agreement between the different subcellular prediction programs in predicting the intracellular location of SFD1. For example, ChloroP 1.1[^1^](#fn1){ref-type="fn"} predicts that SFD1 does not have a chloroplast transit peptide. In contrast, iPSORT[^2^](#fn2){ref-type="fn"} predicts that SFD1 has, at its N-terminus, an apparent chloroplast transit peptide (Figure [1](#F1){ref-type="fig"}A). Here we show that the N-terminal 43 amino acids, which are not essential for SFD1's DHAP reductase activity, are required for proper targeting of SFD1 to chloroplast. Furthermore, we demonstrate that the N-terminal 43 amino acids and DHAP reductase activity of SFD1 are critical for lipid metabolism and its involvement in SAR signaling.

Results
=======

Homology of SFD1 to *leishmania mexicana* GPDH
----------------------------------------------

Sequence alignment of the SFD1 protein to other known GPDHs predicted an NAD-dependent GPDH domain corresponding to amino acid residues 267--411 at the C-terminal half of SFD1, and an NAD-binding domain (residues 88--250) in the N-terminal half of the protein (Figure [1](#F1){ref-type="fig"}A; Nandi et al., [@B25]). A highly conserved NAD^+^/NADH-binding GxGxxG motif is present beginning at amino acid 94 (Figure [1](#F1){ref-type="fig"}A). The crystal structure of the *Leishmania* *mexicana* GPDH (*Lm*GPDH) holo enzyme in complex with NADH revealed that amino acids Lys125, Lys210, and Asp263 of *Lm*GPDH are in the vicinity of the nicotinamide moiety of NADH (Suresh et al., [@B32]). Further study of a ternary complex involving *Lm*GPDH with the substrate DHAP and the product NAD^+^ confirmed that amino acids Lys125, Ser155, Ala157, Lys210, Asn211, Asp263, Thr267, Ser273, Arg274, and Asn275 are part of the active site region (Suresh et al., [@B32]; Choe et al., [@B5]). Alignment of the *Lm*GPDH sequence with the SFD1 amino acid sequence revealed that these amino acids are conserved in SFD1 and correspond to amino acids Lys194, Ser226, Ala228, Lys279, Asn280, Asp332, Thr336, Ser342, Arg343, and Asn344 in SFD1 (Figure [1](#F1){ref-type="fig"}B). In *Lm*GPDH, Lys125, and Lys210 have been shown to form H-bonds with the O-2 atom of DHAP, from which a proton is removed during the oxidation of G3P to DHAP. Furthermore, replacement of Lys125 and Lys210 with Ala or Met in *Lm*GPDH disrupted its enzyme activity (Choe et al., [@B5]). To further determine if Lys194 and Lys279 in SFD1 correspond to Lys125 and Lys210 of *Lm*GPDH, a homology model was generated using SWISS-MODEL[^3^](#fn3){ref-type="fn"}, a protein modeling server (Arnold et al., [@B1]), and the RasMol molecular graphics visualization tool[^4^](#fn4){ref-type="fn"}. Analysis of the derived model of the SFD1-WT protein indicated that the overall structure of SFD1 is similar to that of *Lm*GPDH (Figure [2](#F2){ref-type="fig"}) and includes 17 helices, 12 strands, and 29 turns. Based on this model (Figure [2](#F2){ref-type="fig"}), SFD1 amino acids Lys194 and Lys279 are located in the same position as amino acids Lys125 and Lys210 in *Lm*GPDH. This model also predicts that Asp332 in SFD1, which corresponds to Asp263 in *Lm*GPDH, is adjacent to Lys194 and Lys279 (Figure [2](#F2){ref-type="fig"}) and thus is likely involved in SFD1's DHAP reductase activity.

![**Proposed structure of wild type and mutated SFD1 proteins based on the structure of a *Leishmania mexicana* G3P dehydrogenase**. A ribbon model of the *Leishmania mexicana* 1EVYA GPDH enzyme based on its crystal structure is shown. The structure of the wild type SFD1 protein (SFD1-WT) and the SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 proteins in which residues Lys194, Lys279, and Asp332 are replaced by Ala (denoted as beads), were modeled based on the structure of 1EVYA with the SWISS-MODEL and RasMol 2.7.4.2 [www.rasmol.org](www.rasmol.org) softwares.](fpls-03-00026-g002){#F2}

Biochemical characterization of wild type and mutant SFD1 proteins
------------------------------------------------------------------

To determine if Lys194, Lys279, and Asp332 are critical for SFD1's enzymatic activity, recombinant wild type, and mutant SFD1 proteins in which these amino acids were replaced by Ala were produced in *Escherichia coli*. The recombinant proteins had a His-tag at the C-terminal end, which facilitated their purification over a Ni-column. As shown in Figure [3](#F3){ref-type="fig"}A, the WT and mutant SFD1 proteins exhibited the expected molecular mass of ∼45 kDa. SFD1-WT demonstrated DHAP reductase activity (Figure [3](#F3){ref-type="fig"}B) with Michaelis--Menten kinetics with an apparent *K*~m~ of 0.33 μM for DHAP (Table [1](#T1){ref-type="table"}). Apparent *V*~max~ for SFD1-WT was 49 μmol mg^−1^ min^−1^ (Table [1](#T1){ref-type="table"}). Replacement of any one of the three residues, Lys194, Lys279, and Asp332 with Ala in the SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 recombinant constructs resulted in complete loss of SFD1's DHAP reductase activity (Table [1](#T1){ref-type="table"}).

![**DHAP reductase activity of WT and mutant SFD1 protein**. **(A)** Immunodetection of the recombinant SFD1 proteins with anti-His-tag antibody. **(B)** DHAP reductase activity of the purified recombinant SFD1-WT and SDF1Δ43 proteins. DHAP reductase activity was measured as the rate of decrease in A~340 nm~ due to oxidation of NADH to NAD^+^. No activity was detected with the recombinant SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 proteins. **(C)** Functional complementation of an *E. coli* G3P auxotrophic mutant by WT and mutant SFD1 proteins. Growth of the *E. coli* DHAP reductase-deficient strain BB20-14 expressing the WT and mutant SFD1 constructs on minimal liquid M9 medium with or without 0.1% glycerol. The empty pET28c vector-transformed *E. coli* provided the negative control. Cell growth was determined by measuring the optical density at *A*~600~. G+, supplemented with glycerol; G−, without glycerol.](fpls-03-00026-g003){#F3}

###### 

**DHAP reductase activity of WT and mutant SFD1 proteins**.

  SFD1 construct   *K*~m~ (μM)   *V*~max~ (μmol mg^−1^ min^−1^)
  ---------------- ------------- --------------------------------
  SFD1-WT          0.33 ± 0.16   49.24 ± 4.58
  SFD1Δ43          0.20 ± 0.05   41.11 ± 1.93
  SFD1--Ala194     nd            nd
  SFD1--Ala279     nd            nd
  SFD1--Ala332     nd            nd

*nd, No activity detected*.

Further confirmation of the importance of Lys194, Lys279, and Asp332 for SFD1's enzymatic activity was obtained by expressing the Ala-substituted mutant proteins and the SFD1-WT protein in the *E. coli* *gpsA* mutant strain BB20-14. This *E. coli* mutant lacks a GPDH activity resulting in G3P auxotrophy, which can be complemented by glycerol (Cronan and Bell, [@B8]) and by the expression of SFD1 (Kachroo et al., [@B17]; Nandi et al., [@B25]). As shown in Figure [3](#F3){ref-type="fig"}C, unlike the SFD-WT construct, the SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 mutant constructs were unable to complement the G3P auxotrophy of the *E. coli* *gpsA* mutant strain BB20-14. The Ala substitutions in SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 are predicted to not have any significant impact on the structure of SFD1 (Figure [2](#F2){ref-type="fig"}). Taken together the above results confirm that Lys194, Lys279, and Asp332 are critical for SFD1's DHAP reductase activity.

SFD1's DHAP reductase activity is critical for its involvement in SAR and lipid metabolism
------------------------------------------------------------------------------------------

To determine if SFD1's DHAP reductase activity is required for its involvement in SAR, the SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 mutant constructs were expressed from the *Cauliflower mosaic virus 35S* gene promoter in the *sfd1-1* mutant background. Plants transformed with the SFD1-WT and empty vector provided the positive and negative controls, respectively, for these experiments. The WT accession Nössen and *sfd1-1* mutant plant provided additional controls. Reverse-transcription polymerase chain reactions (RT-PCR) analysis confirmed that compared to the *sfd1-1* mutant and *sfd1-1* mutant plants transformed with the pMDC32 empty vector (Vect), the *SFD1* transcript accumulated at high levels in transgenic plants with the wild type SFD1 (SFD1-WT) and SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 mutant constructs (Figure [4](#F4){ref-type="fig"}A). To monitor SAR in these transgenics, a mix of plants derived from three independent transgenic lines for each construct were used. SAR was induced by inoculating (1° inoculation) three fully expanded lower leaves of each plant with a suspension (in 10 mM MgCl~2~) of an avirulent strain of *P. syringae* pv. *tomato* DC3000 (*Pto--avrRpt2*). Three days later, four upper leaves were challenged (2° inoculation) with *P. syringae* pv. *maculicola* (*Pma*), a virulent pathogen, and bacterial numbers in these *Pma*-inoculated leaves monitored 3 days post inoculation (3 dpi). Plants that received a 1° inoculation of 10 mM MgCl~2~ provided the negative control for comparing the extent of SAR-enhanced resistance to *Pma*. As shown in Figure [4](#F4){ref-type="fig"}B, in the WT plant *Pma* numbers were significantly lower in the plants that received a 1° inoculation of *Pto--avrRpt2* than in those that were treated with 10 mM MgCl~2~, indicating that SAR was activated. In contrast, as previously demonstrated (Nandi et al., [@B25]; Chaturvedi et al., [@B4]), SAR was not activated in the *sfd1-1* mutant. *Pma* numbers were comparable in the upper leaves of the *sfd1-1* mutant plants that were previously treated with 10 mM MgCl~2~ or *Pto--avrRpt2*. Like the *sfd1-1* mutant and the empty vector (Vect) transformed *sfd1-1* mutant plants, SAR was also not activated in transgenic plants transformed with the SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 mutant constructs, confirming that these amino acids, which are critical for SFD1's DHAP reductase activity are also required for SFD1's involvement in SAR.

![**Systemic acquired resistance in *sfd1-1* transgenic plants expressing the wild type and mutant SFD1**. **(A)** RT-PCR analysis of the SFD1 transgene expression in leaves of the *sfd1-1* mutant plants transformed with the empty pMDC32 vector (Vect), the wild type (SFD1-WT) and the SFD1Δ43, SFD1--Ala194, SFD1--Ala279, and SFD1--Ala332 mutant constructs, and the SFD1--GFP and SFD1Δ43--GFP protein fusion expressing constructs. RNA extracted from non-transformed *sfd1-1* mutant provided the negative control (−). The attR1-F plus a reverse primer (SFD-RCt) specific for the C-terminus of *SFD1* were used for the PCR reaction to monitor expression of the *SFD1* transgenes. This primer pair does not detect expression of the genomic *SFD1*. Expression of the *ACTIN* gene, *ACT8*, provided the control for RT-PCR. **(B)** SAR conferred resistance against *P. syringae* pv. *maculicola* in the wild type (WT) *Arabidopsis* accession Nössen plant, the *sfd1-1* mutant, and *sfd1-1* mutant plants transformed with the indicated constructs. SAR was induced by prior inoculation of a lower leaf with *P. syringae* pv. *tomato* DC3000 carrying the *avrRpt2* avirulence gene (black bars). Plants similarly treated with 10 mM MgCl~2~ (white bars) provided the mock control for SAR. Three days after the primary inoculation the distal leaves were challenged with *P. syringae* pv. *maculicola* (*Pma*). *Pma* numbers were monitored 3 days post inoculation. Each bar represents the average colony forming units (CFU) of *Pma* ± SD in three samples each containing five leaf disks. An \*indicates significant (*P *\< 0.05) differences in bacterial numbers relative to the corresponding mock control.](fpls-03-00026-g004){#F4}

Expression of SFD1-WT also complemented the galactolipid defect of the *sfd1-1* allele. As previously demonstrated and shown in Figures [5](#F5){ref-type="fig"}A,B, the *sfd1-1* mutation resulted in a reduction in the content of the plastid synthesized 34:6-MGDG. Furthermore, a corresponding increase in 36:6-MGDG, which is synthesized from DAG derived from the ER pathway, was also observed in the *sfd1-1* mutant. To determine if the DHAP reductase activity of SFD1 is essential for its involvement in lipid metabolism, 34:6- and 36:6-MGDG content were compared between the SFD1-WT and SFD1--Ala279 transgenic plants. The WT and the *sfd1-1* mutant provided additional controls. As shown in Figure [5](#F5){ref-type="fig"}A, in comparison to the SFD1-WT plant*s*, 34:6-MGDG content as a fraction of total MGDG was lower in the SFD1--Ala279 plant and 36:6-MGDG content was higher. The 34:6- and 36:6-MGDG contents in the SFD1--Ala279 plant were comparable to those in the s*fd1-1* mutant plant, thus confirming that Lys279, and hence SFD1's DHAP reductase activity is critical for its involvement in *Arabidopsis* lipid metabolism.

![**34:6- and 36:6-MGDG content in *sfd1-1* transgenic plants expressing wild type and mutant *SFD1***. **(A)** 34:6- and 36:6-MGDG content in the wild type accession Nössen (WT), *sfd1-1*, and *sfd1-1* transformed with the SFD1-WT and SFD1--Ala279 mis-sense mutant. **(B)** 34:6- and 36:6-MGDG content in the WT, *sfd1-1*, and *sfd1-1* transformed with the empty pMDC32 vector (Vect) and the SFD1Δ43 construct. In **(A,B)**, all values are the average (±SD) of five independent samples given as the fraction of 34:6- and 36:6-MGDG species relative to the total MGDG content. An \*denotes significant (*P *\< 0.05) differences relative to the WT. A \*\*denotes significant (*P *\< 0.05) differences relative to all other genotypes.](fpls-03-00026-g005){#F5}

SFD1 is localized to the chloroplast
------------------------------------

As mentioned above and indicated in Figure [1](#F1){ref-type="fig"}A, iPSORT predicts that SFD1 has at its N-terminus a chloroplast targeting sequence. Furthermore, proteomics studies have identified SFD1 in the envelope fraction of chloroplasts (Joyard et al., [@B14]). We tested chloroplast localization of SFD1 in transgenic plants that expressed SFD1 fused to green fluorescent protein (GFP). GFP was fused to the last (carboxyl terminal) amino acid of SFD1. RT-PCR analysis confirmed expression of the transgene in the SFD1--GFP plants (Figure [4](#F4){ref-type="fig"}A). Expression of the SFD1--GFP fusion also complemented the SAR defect of the *sfd1-1* mutant (Figure [6](#F6){ref-type="fig"}A), confirming that the fusion protein was biologically functional. By comparison, expression of GFP alone was unable to complement the SAR defect of the *sfd1-1* mutant. The GFP fluorescence (green) and red autofluorescence of chloroplasts was monitored in protoplasts isolated from the SFD1--GFP transformed *sfd1-1* plants, and, as controls in protoplasts isolated from *sfd1-1* plants expressing GFP and the non-transformed *sfd1-1* plants. As shown in Figure [6](#F6){ref-type="fig"}B, protoplasts derived from the SFD1--GFP transformed line exhibited a GFP fluorescence pattern that overlapped very well with the red autofluorescence of chloroplasts, confirming that SFD1--GFP fusion is localized to the chloroplast. By contrast, in protoplasts expressing GFP alone, strong green fluorescence was observed outside the chloroplasts. As expected, green fluorescence was not observed in protoplasts derived from the non-transformed *sfd1-1* plants.

![**The N-terminal 43 amino acids of SFD1 are required for targeting SFD1 to the chloroplast**. **(A)** SAR conferred resistance against *P. syringae* pv. *maculicola* (*Pma*) in the wild type (WT) *Arabidopsis* accession Nössen plant, and in transgenic *sfd1-1* mutant plants that express GFP or the SFD1--GFP and SFD1Δ43--GFP constructs in which the GFP coding sequence is fused in frame to the C-terminus of the SFD1 protein. Refer to legend to Figure [4](#F4){ref-type="fig"}B on details for the induction of SAR. An \*indicates significant (*P *\< 0.05) differences in *Pma* numbers in plants that were previously treated with an avirulent pathogen (black bars) relative to plants that received a prior mock treatment (white bars). **(B)** The green fluorescence of GFP and red autofluorescence of chloroplasts were observed in protoplasts isolated from leaves of 4-week-old *sfd1-1* mutant, and transgenic s*fd1-1* mutant plants expressing GFP, SFD1--GFP, and SFD1Δ43--GFP. Merged images of green fluorescence of GFP and red autofluorescence of chloroplasts are also depicted.](fpls-03-00026-g006){#F6}

To determine if the N-terminus of SFD1, which contains the predicted chloroplast targeting sequence, is required for targeting SFD1 to the chloroplast, a SFD1Δ43--GFP construct was generated in which the N-terminal 43 amino acids of SFD1 were deleted and GFP was fused to the last (carboxyl terminal) amino acid of SFD1. RT-PCR confirmed that the SFD1Δ43--GFP construct was expressed in the transgenic plants (Figure [4](#F4){ref-type="fig"}A). Protoplasts derived from transgenic *sfd1-1* plants expressing the SFDΔ43--GFP construct were observed for GFP fluorescence pattern. As shown in Figure [6](#F6){ref-type="fig"}B, the GFP fluorescence pattern of SFD1Δ43--GFP showed a punctate pattern that did not overlap with the red autofluorescence of chloroplasts, thus indicating that the N-terminal 43 amino acids are required for proper targeting of SFD1 to chloroplasts.

N-terminal 43 amino acids are critical for SFD1's involvement in lipid metabolism and defense signaling
-------------------------------------------------------------------------------------------------------

The SFD1Δ43 protein expressed and purified from *E. coli* (Figure [3](#F3){ref-type="fig"}A) exhibited DHAP reductase activity with an apparent *K*~m~ of 0.2 μM for DHAP and *V*~max~ of 41 μmol mg^−1^ min^−1^ (Figure [3](#F3){ref-type="fig"}B; Table [1](#T1){ref-type="table"}). In addition, this construct efficiently complemented the G3P auxotrophy of the *E. coli* *gpsA* mutant strain BB20-14 (Figure [3](#F3){ref-type="fig"}C), thus indicating that the N-terminal 43 amino acids of SFD1 are not critical for its DHAP reductase activity. However, expression of SFD1Δ43 in transgenic plants did not complement the MGDG defect of the *sfd1-1* mutant (Figure [5](#F5){ref-type="fig"}B). Furthermore, SFD1Δ43 was unable to restore SAR in the *sfd1-1* mutant background (Figure [4](#F4){ref-type="fig"}B). Similarly, the SFD1Δ43--GFP fusion was unable to complement the SAR defect of *sfd1-1* (Figure [6](#F6){ref-type="fig"}A). Taken together, these results indicate that the N-terminal 43 amino acids, which are required for targeting SFD1 to chloroplasts, are critical for SFD1's involvement in SAR and lipid metabolism.

Discussion
==========

The *Arabidopsis* *SFD1* gene was previously demonstrated to be required for long-distance signaling associated with the activation of SAR and the accumulation of 34:6-MGDG, a major glycerolipid that is synthesized in the plastid (Nandi et al., [@B25]; Chaturvedi et al., [@B4]). Evidence provided here demonstrates that SFD1's DHAP reductase activity is essential for its involvement in SAR and the accumulation of 34:6-MGDG. Ala substitution of Lys194, Lys279, and Asp332 in SFD1, which correspond to the critical active site residues in the *L. mexicana* *Lm*GPDH, resulted in loss of SFD1's DHAP reductase activity (Table [1](#T1){ref-type="table"}), and in its ability to complement the SAR and the 34:6-MGDG composition defect of the *sfd1-1* mutant (Figures [4](#F4){ref-type="fig"}B and [5](#F5){ref-type="fig"}A). Fluorescence microscopy of cells expressing GFP-tagged SFD1 revealed that the SFD1 protein is localized to the chloroplasts (Figure [6](#F6){ref-type="fig"}B). These results are in agreement with a recent proteomic study, in which SFD1 was recovered with the envelope fraction of chloroplasts (Joyard et al., [@B14]). The N-terminal 43 amino acids were required for the proper localization of SFD1 to chloroplasts (Figure [6](#F6){ref-type="fig"}B). The SFD1Δ43 protein, which lacks these 43 amino acids, was unable to complement the SAR and 34:6-MGDG deficiency of the *sfd1-1* mutant allele (Figures [4](#F4){ref-type="fig"}B and [5](#F5){ref-type="fig"}B). Similarly, the SFD1Δ43--GFP fusion protein was also unable to restore SAR in the *sfd1*-*1* mutant background (Figure [6](#F6){ref-type="fig"}A). Since the SFD1Δ43 protein possesses DHAP reductase activity, these results suggest that the proper targeting of SFD1 to chloroplasts is critical for its involvement in SAR signaling and lipid metabolism.

The SFD1Δ43 protein retains DHAP reductase activity and is as active as the WT SFD1 protein *in vitro* (Figure [3](#F3){ref-type="fig"}B; Table [1](#T1){ref-type="table"}). However, since SFD1Δ43 does not exhibit chloroplast localization, any G3P synthesized outside the chloroplast by this protein is not sufficient to compensate for the deficiency of the *sfd1-1* mutant, thus suggesting that G3P synthesized within the chloroplast is critical for SAR and galactolipid metabolism. The At5g40610-encoded AtGPDHp is another chloroplastic DHAP reductase from *Arabidopsis* that has been biochemically characterized (Wei et al., [@B34]). Many features of AtGPDHp are similar to that of SFD1. Both proteins are of comparable size (40--45 kDa) and have *K*~m~'s for DHAP that are in the low micro molar range (AtGPDHp *K*~m~ = 13 μM; SFD1 *K*~m~ = 0.3 μM). In addition, AtGPDHp has a pH optimum of 7.5 that is comparable to that of recombinant SFD1 (optimum pH 7.2), and both proteins are localized to the chloroplast. AtGPDHp exhibits 29% (101 of 343 amino acids) identity and 46% (158 of 343 amino acids) similarity with SFD1 (Krothapalli, [@B20]). However, unlike SFD1, knock-out of *AtGPDHp* did not have a major impact on the content and composition of galactolipid and other glycerolipids in the *atgphdp* mutant (Krothapalli, [@B20]). Furthermore, Krothapalli ([@B20]) found that the *atgphdp* mutant, unlike the *sfd1* mutant, was SAR-competent and the severity of SAR-deficiency was comparable between *sfd1* single mutant and the *sfd1 atgpdhp* double mutant, suggesting that unlike SFD1, the AtGPDHp protein does not have a major role in leaf glycerolipid synthesis and SAR signaling. However, while this manuscript was being prepared, another study showed that SAR was compromised in an *atgpdhp* mutant (Chanda et al., [@B3]). Although the reason for the discrepancy between these two independent studies (Krothapalli, [@B20]; Chanda et al., [@B3]) is not clear, it is quite possible that the involvement of the *atgpdhp* gene in SAR is conditioned by other factors and is required under certain conditions, but not in others. However, in concordance with a lack of effect of the *AtGPDHp* gene in defense, *AtGPDHp* is not required for *Arabidopsis* resistance to *C. higginsianum* as *SFD1* is (Chanda et al., [@B2]). *AtGPDHp*'s lack of effects or low-level effects on SAR and lipid metabolism may be due to its weak expression in leaf tissue, compared to its expression in floral tissues, siliques, and young seedlings (Wei et al., [@B34]). It is also plausible that SFD1 and AtGPDHp are expressed in different cell types. Thus, G3P synthesized by these two enzymes has different functions in *Arabidopsis*. Alternatively, *Arabidopsis* leaf cells may contain different pools of G3P in the plastid, with the SFD1-derived G3P pool contributing to galactolipid metabolism and SAR and the AtGPDHp-derived G3P pool presumably contributing to other biochemical processes.

In agreement with the results presented here demonstrating that the DHAP reductase activity of SFD1 is required for SAR, Chanda et al. ([@B3]) demonstrated that applying G3P, along with vascular sap from uninfected wild type plants, complements the SAR defect in a *gly1* (*sfd1*) mutant. However, in the absence of vascular sap, G3P was not capable of restoring SAR in the *gly1* mutant, suggesting that an additional factor that is present in vascular sap is required for the G3P-induced systemic resistance. Furthermore, G3P, when applied with vascular sap from uninfected plants was unable to induce the systemic accumulation of salicylic acid that is observed in biologically induced SAR. Rather, G3P-induced accumulation of azelaic acid (Chanda et al., [@B3]), a defense priming metabolite, which like G3P can enhance the strength of SAR (Jung et al., [@B15]). The *sfd1* mutant is also less sensitive to dehydroabietinal, a C~20~ abietane diterpenoid that was recently identified as a vascular translocated factor, and the most potent activator of SAR (Shah, [@B28]; R. Chaturvedi and J. Shah, unpublished). Unlike, G3P and azelaic acid, local application of dehydroabietinal leads to a systemic induction in salicylic acid accumulation and enhanced disease resistance. Taken together, these results suggest that SFD1 has an additional function in SAR that promotes the effect of dehydroabietinal in SAR.

In summary, results presented here demonstrate that SFD1's DHAP reductase activity is required in the chloroplast for its participation in lipid metabolism and defense signaling.

Materials and Methods
=====================

Plant and pathogen cultivation
------------------------------

*Arabidopsis thaliana* plants were grown at 22°C in growth chambers/rooms programmed for 14 h light (100 μE m^−2^ s^−1^) and 10 h dark cycle in autoclaved peat-based planting mixture (Premier Pro Mix-PGX, Premier Tech Horticulture[^5^](#fn5){ref-type="fn"}).

Pathogen inoculations
---------------------

A suspension (10^7^ cfu ml^−1^ in 10 mM MgCl~2~) of an avirulent strain of *Pseudomonas syringae* pv. *tomato* DC3000 carrying the *avrRpt2* avirulence gene (*Pto--avrRpt2*) was infiltrated (1° inoculation) into three fully expanded leaves to activate SAR, as previously described (Chaturvedi et al., [@B4]). 10 mM MgCl~2~-infiltrated plants provided the mock controls. Three days later, four upper leaves were challenged (2° inoculation) with a suspension (10^5^ cfu ml^−1^) of the virulent pathogen *P. syringae* pv *maculicola* ES4326 (*Pma*). Three days after the 2° inoculation the *Pma*-inoculated leaves were harvested and bacterial counts in leaf disks (area = 0.28 cm^2^) determined as previously described (Chaturvedi et al., [@B4]). A total of 15 leaf disks (three replications of five leaf disks in each sample) were analyzed for each treatment.

Plasmids for *in planta* expression of recombinant SFD1 protein
---------------------------------------------------------------

DNA containing wild type, truncated and mutant versions of the SFD1 open reading frames were cloned in the pET28c vector (Novagen[^6^](#fn6){ref-type="fn"}) to generate SFD1-WT (full length), SDF1Δ43 (lacks DNA encoding the N-terminal 43 amino acids of SFD1), and SFD1--Ala194, SFD1--Ala297, and SFD1--Ala332 in which Lys at amino acids 194 and 279, and Asp at 332 were replaced by Ala, respectively. The pET28c− SFD1-WT clone was generated by ligating the SFD1 cDNA from the plasmid U10925 (obtained from the *Arabidopsis* Biological Resource Center, Ohio State University[^7^](#fn7){ref-type="fn"}) into the *Eco*RI and *Sal*I sites of pET28c. Two sets of PCR reactions were set up in which the wild type SFD1 clone in pET28c (SFD1-WT) was used as a template to generate the SFD1--Ala194, SFD1--Ala297, and SFD1--Ala332 mutant constructs. For construction of SFD1--Ala194 the first set of PCR reactions utilized the forward mutagenic primer SFD1-a1 and the T7-R primer (Table [2](#T2){ref-type="table"}) to amplify SFD1 sequences 3′ to the region spanning amino acid 194. The second set of reactions involved the T7-F primer and the reverse mutagenic primer SFD1-a2 to amplify SFD1 sequences 5′ to the region spanning amino acid 194. Both reaction products were subsequently combined, diluted, and used as a template in a PCR reaction with the T7-F and T7-R primers. The resultant PCR product was treated with *Eco*RI and *Sal*I (New England Biolabs[^8^](#fn8){ref-type="fn"}) and the digested amplicon cloned between the *Eco*RI and *Sal*I sites of pET28c to yield pET28c− SFD1--Ala194. The SFD1--Ala297 and SFD1--Ala332 constructs were similarly made using the SFD1-b1 and SFD1-b2, and SFD1-c1 and SFD1-c2 mutant primers, respectively. To generate the pET28c− SDF1Δ43 construct, the PCR product derived with the SDF1Δ43-F1 and SDF1Δ43-R1 primers was first ligated into pGEM-T Easy vector (Promega[^9^](#fn9){ref-type="fn"}). The insert was subsequently excised with *Bam*HI and *Sal*I and cloned into the *Bam*HI and *Sal*I linearized pET28a vector. All constructs were sequenced to confirm the presence of the desired mutations and lack of any other unwanted alterations. The sequences of primers used in this study are provided in Table [2](#T2){ref-type="table"}.

###### 

**Primers used in this study**.

  Primer name           Sequence 5′ → 3′
  --------------------- ------------------------------------------
  SFD1-a1               CCTTTTATATCTCTTAGCGCGGGTCTGGAGCTTAATACTC
  SFD1-a2               GAGTATTAAGCTCCAGACCCGCGCTAAGAGATATAAAAGG
  SFD1-b1               GAAATCGCCGGTGCCCTGGCGAATGTTCTAGCAATAG
  SFD1-b2               CTATTGCTAGAACATTCGCCAGGGCACCGGCGATTTC
  SFD1-c1               GTTTATCAGGAACTGGGGCGATAATGCTTACGTGTTTTG
  SFD1-c2               CAAAACACGTAAGCATTATCGCCCCAGTTCCTGATAAAC
  SDF1ΔNt~43~-F1        GGATCCGAATTCATCTCTGGTCCGCCTG
  SDF1ΔNt~43~-R1        AAGCTTGTCGACTCATACTTCTTCAATCTGAGG
  SDF1ΔNt~43~-F2start   ATCTCTGGTCCGCCTGATATC
  SDF1ΔNt~43~-R2stop    TCATACTTCTTCAATCTGAGGA
  SDF1ΔNt~43~-R2Ct      TACTTCTTCAATCTGAGGAAG
  SFD1-Fstart           ATGGCGGCTTCGGTGCAACCTGC
  SFD1-Rstop            TCATACTTCTTCAATCTGAGGA
  SFD1-RCt              TACTTCTTCAATCTGAGGAAG
  T7-F                  TAATACGACTCACTATAGGG
  T7-R                  TAGTTATTGCTCAGCGGTGG
  Hyg-F                 GATGTTGGCGACCTCGTATT
  Hyg-R                 GATGTAGGAGGGCGTGGATA
  attR1-F               TTGGAGAGGACCTCGACTCT

To generate clones for expressing wild type and mutant versions of SFD1 *in planta*, the pET28c− SFD1-WT, pET28c− SFD1--Ala194, pET28c− SFD1--Ala279, and pET28c− SFD1--Ala332 vectors were used as templates in PCR reactions to amplify the SFD1-WT, SFD1--Ala194, SFD1--Ala297, and SFD1--Ala332 DNA with the SFD1-F start and SFD1-R stop primers. To generate a clone for expressing SFD1Δ43 *in planta*, the pET28c− SFD1Δ43 plasmid was used as a template in PCR with the primers SFD1Δ43-F2 and SFD1Δ43-R2stop. The amplified products were cloned into pCR^®^8/GW/TOPO^®^ vector (Invitrogen). The inserts in the resultant plasmids were fully sequenced and used for the LR recombination reaction with the destination vector pMDC32 (Invitrogen; Curtis and Grossniklaus, [@B9]), which contains the Cauliflower mosaic virus *35S* gene promoter. To generate constructs expressing SFD1--GFP and SFD1Δ43--GFP in *Arabidopsis*, the pET28c− SFD1-WT and pET28c− SFD1Δ43 plasmids were used as templates in PCR reactions with the primer pairs SFD1-Fstart plus SFD1-RCt, and SFD1Δ43-F2 plus SFD1Δ43-R2Ct, respectively. The amplified products were cloned into the pCR^®^8/GW/TOPO^®^ vector. The resultant plasmids were used in the LR recombination reaction with destination vector pMDC83, such that the GFP coding sequence in pMDC83 was fused in frame to the C-terminal amino acid of the SFD1 protein (Curtis and Grossniklaus, [@B9]). The pMDC32 empty vector and pMDC83 empty vectors were obtained through LR reaction of pCR^®^8/GW/TOPO^®^ empty vector with pMDC32 and pMDC83, respectively.

Plant transformation
--------------------

pMDC32 and pMDC83 plasmids containing the desired inserts were electroporated into the *Agrobacterium tumefaciens* strain GV3101. Presence of the corresponding plasmids in the GV3101 transformants was confirmed by PCR. GV3101 transformants containing pMDC32 or pMDC83 with inserts of interest were used to transform *sfd1-1* mutant plants by the floral dip method (Clough and Bent, [@B7]). Hygromycin resistant seeds were selected on MS agar plates supplemented with hygromycin (20 μg ml^−1^). Expression of the transgene was confirmed by RT-PCR analysis. Plants from three independently derived transgenic lines for each construct were mixed and used for SAR bioassays and lipid analysis.

RNA extraction and RT-PCR analysis
----------------------------------

Leaf tissue was ground in liquid nitrogen and RNA was extracted using an acid guanidinium thiocyanate/phenol/chloroform mix (Chomczynski and Sacchi, [@B6]). The isolated RNA was purified and used in the RT-PCR. The PCR primers for the ACT8 gene (At1g49240) were as previously described (Pegadaraju et al., [@B26]). To confirm expression of the hygromycin resistance selection marker (data not shown) and the chimeric SFD1 transgenes, the RT step was followed by PCR with Hyg-F plus Hyg-R, and the attR1-F plus a reverse primer (SFD1-RCt) specific for the C-terminus of *SFD1*, respectively. Primer sequences can be found in Table [2](#T2){ref-type="table"}. The PCR with the Hyg-F plus Hyg-R primers was performed with the following conditions: 95°C for 5 min followed by 25 cycles of 95°C for 30 s, 50°C for 45 s, 72°C for 1 min, with final extension at 72°C for 10 min. The PCR with the attR1-F plus the SFD1-RCt primers was performed with the following conditions: 95°C for 5 min followed by 35 cycles of 95°C for 30 s, 55°C for 45 s, 72°C for 1 min, with final extension at 72°C for 10 min.

Subcellular localization of SFD1--GFP protein
---------------------------------------------

Leaves were cut from the 4-week-old transgenic plants and used for enzymatic protoplasts isolation. Protoplasts were prepared by incubating leaves at room temperature for 2 h in a solution containing 1% cellulase, 0.3% macerozyme, 0.4 M mannitol, 20 mM KCl, and 20 mM MES (pH 6.0). The protoplasts were washed with the protoplast storage buffer (0.5 M mannitol, 20 mM KCl, 4 mM MES pH 6.0) before analysis. GFP fluorescence and chloroplast autofluorescence were monitored using a Zeiss Axiovert 200 M optical microscope connected with a Hamamatsu camera and Yokogawa Confocal Scanner Unit CSU10. Excitation wavelengths/emission filters were 488 nm/band-pass 505--535 nm for GFP and 488 nm/band-pass 672--712 nm for chloroplast autofluorescence. The entire system was controlled with Simple PCI software from Hamamatsu Corporation.

Recombinant protein purification and enzyme assays
--------------------------------------------------

A recombinant SFD1-WT, SDF1Δ43, and mis-sense mutant fusion proteins (SFD1--Ala194, SFD1--Ala297, and SFD1--Ala332) containing a 6× His-tag were expressed from the pET28c vector in *E. coli* and then purified under native conditions over an affinity Ni-NTA column (Qiagen). *E. coli* strains BL21 containing (WT) and mutant SFD1 plasmids were cultured in LB medium supplemented with 50 μg ml^−1^ kanamycin at 37°C. Induction of SFD1 and mutant proteins expression was achieved by adding 1 mM IPTG. Cells were harvested and broken down through sonication. Induction of protein and further purification were performed according to suggested protocols (The QIAexpressionist^TM^, QIAGEN). The protein concentration was determined using Bio-Rad protein assay kit (Bio-Rad), with BSA used as a standard. The BL21 strain harboring the pET28c empty vector was cultured and treated in parallel as a control. To determine the pH optimum for SFD1, recombinant SFD1 protein was incubated at 30°C in a reaction mixture containing 0.16 mM NADH, 1 mM DTT, 10 mM DHAP in 100 mM HEPES buffer of varying pH. The final volume of the reaction mix was 500 μl. The pH optimum for SFD1's DHAP reductase activity was determined to be 7.2. The assay was based on the DHAP-dependent oxidation of NADH to NAD^+^ and consisted of two stages. The background of NADH oxidation was first determined in reaction mixtures without DHAP, after which DHAP was added at 5--200 μM and the reductase activity measured. The activity measured was the rate of decrease in A~340~ due to oxidation of NADH to NAD^+^. For measuring the kinetic constants the reaction was conducted at pH 7.2. The GraphPad Prism 5 program was used to determine kinetic constants. The WT SFD1 protein retained DHAP reductase activity when kept overnight at room temperature. The enzyme was unstable if left at 4°C or lower temperature. Stability of the SFD1 protein was achieved by storage in 2 M glycerol and addition of 1 mM DTT. To reactivate the enzyme it was heated to 30°C for 10 min.

Complementation of bacterial strain BB20-14
-------------------------------------------

*Escherichia coli* gpsA mutant strain BB20-14 (Cronan and Bell, [@B8]) was obtained from the *E. coli* Genetic Stock Center at Yale University. BB20-14 was maintained in M9 medium (Sambrook et al., [@B27]) supplemented with 0.4% glucose, 1 mM MgSO~4~, 100 μM CaCl~2~, and 1% glycerol (v/v). BB20-14 was transformed with empty pET28c vector and pET28c vectors containing cDNA of SFD1-WT, SDF1Δ43 and different mis-sense SFD1 versions. The transformation mix was plated on M9 agar supplemented with kanamycin (50 μg mL^−1^), 0.4% glucose, 1 mM MgSO~4~, 100 μM CaCl~2~ and 0.1% glycerol (v/v). Kanamycin-resistant colonies were inoculated into liquid M9 medium containing kanamycin (50 μg mL^−1^), 1 mM IPTG, 1 mM MgSO~4~, 100 μM CaCl~2~ with or without 0.1% glycerol. Bacteria were grown at 37°C for 2 days and the absorbance at *A*~600~ was determined.

Lipid extraction and ESI-MS/MS analysis
---------------------------------------

Lipids were extracted using the protocol available at the Kansas Lipidomics Research Center website[^10^](#fn10){ref-type="fn"} and analyzed by MS as previously described (Xiao et al., [@B35]). Unfractionated lipid extracts were introduced by continuous infusion into the ESI source on a triple quadrupole MS/MS (API 4000, Applied Biosystems, Foster City, CA, USA) at 30 μl/min. MGDG was detected as \[M + NH~4~\]^+^ in positive ion mode with Neutral Loss of 179.1. The lipids in each class were quantified in comparison to 2.01 nmol 16:0--18:0-MGDG and 0.39 nmol di18:0-MGDG internal standards.
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Erratum
-------

On page 7, last paragraph, right column of this article, it was mistakenly stated "However, in concordance with a lack of effect of the AtGPDHp gene in defense, AtGPDHp is not required for Arabidopsis resistance to C. higginsianum as SFD1 is (Chanda et al., [@B2])." The authors would like to rectify that Chanda et al. ([@B2]) showed that mutation in another GPDH encoding gene, At2g41540, did not impact resistance against this fungus. They did not report the effect of AtGPDHp encoded by At5g40610 on Arabidopsis resistance to Colletotrichum higginsianum. In addition, on page 8, the fourth sentence of the first full paragraph, left column, should read "Similarly, G3P was unable to induce accumulation of azelaic acid (Chanda et al., [@B3]), a defense priming metabolite, which can enhance the strength of SAR (Jung et al., [@B15])." and not "Rather, G3P-induced accumulation of azelaic acid (Chanda et al., [@B3]), a defense priming metabolite, which like G3P can enhance the strength of SAR (Jung et al., [@B15])".
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